Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial

OBJECTIVE: To evaluate the safety and efficacy of ospemifene for the treatment of moderate to severe vaginal dryness in postmenopausal women with vulvovaginal atrophy (VVA). METHODS: This 12-week, multicenter, double-blind phase 3 study randomized postmenopausal women (aged 40-80 years) with VVA and...

Descripción completa

Detalles Bibliográficos
Autores principales: Archer, David F., Goldstein, Steven R., Simon, James A., Waldbaum, Arthur S., Sussman, Steven A., Altomare, Corrado, Zhu, Julie, Yoshida, Yuki, Schaffer, Sam, Soulban, Graziella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott-Raven Publishers 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553508/
https://www.ncbi.nlm.nih.gov/pubmed/30694917
http://dx.doi.org/10.1097/GME.0000000000001292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553508/
https://www.ncbi.nlm.nih.gov/pubmed/30694917
http://dx.doi.org/10.1097/GME.0000000000001292

Ejemplares similares